Search

Author/Creator Perkins, C.

5. Measurements of dihadron correlations relative to the event plane in Au+Au collisions at GeV *Supported in part by the Offices of NP and HEP within the U.S. DOE Office of Science, the U.S. NSF, the Sloan Foundation, the DFG cluster of excellence 'Origin and Structure of the Universe' of Germany, CNRS/IN2P3, STFC and EPSRC of the United Kingdom, FAPESP CNPq of Brazil, Ministry of Ed. and Sci. of the Russian Federation, NNSFC, CAS, MoST, and MoE of China, GA and MSMT of the Czech Republic, FOM and NWO of the Netherlands, DAE, DST, and CSIR of India, Polish Ministry of Sci. and Higher Ed., Korea Research Foundation, Ministry of Sci., Ed. and Sports of the Rep. Of Croatia, Russian Ministry of Sci. and Tech, and RosAtom of Russia. (April 2021)

Authors:
Agakishiev, H.; Aggarwal, M. M.; Ahammed, Z.; Alakhverdyants, A. V.; Alekseev, I.; Alford, J.; Anderson, B. D.; Anson, C. D.; Arkhipkin, D.; Averichev, G. S.; Balewski, J.; Beavis, D. R.; Behera, N. K.; Bellwied, R.; Betancourt, M. J.; Betts, R. R.; Bhasin, A.; Bhati, A. K.; Bichsel, H.; Bielcik, J.
Journal:
Chinese physics C
Issue:
Volume 45:Number 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY. (23rd June 2022)

Authors:
Reiter, A.; Gotlib, J.; Álvarez-Twose, I.; Radia, D. H.; Luebke, J.; Bobbili, P. J.; Wang, A.; Norregaard, C.; Dimitrijević, S.; Sullivan, E.; Louie-Gao, M.; Schwaab, J.; Galinsky, I. A.; Perkins, C.; Sperr, W. R.; Sriskandarajah, P.; Chin, A.; Sendhil, S. R.; Duh, M. S.; Valent, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
903
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE. (23rd June 2022)

Authors:
Reiter, A.; Gotlib, J.; Álvarez-Twose, I.; Radia, D. H.; Luebke, J.; Bobbili, P. J.; Wang, A.; Norregaard, C.; Dimitrijević, S.; Sullivan, E.; Louie-Gao, M.; Schwaab, J.; Galinsky, I. A.; Perkins, C.; Sperr, W. R.; Sriskandarajah, P.; Chin, A.; Sendhil, S. R.; Duh, M. S.; Valent, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY. (23rd June 2022)

Authors:
Reiter, A.; Gotlib, J.; Álvarez-Twose, I.; Radia, D. H.; Luebke, J.; Bobbili, P. J.; Wang, A.; Norregaard, C.; Dimitrijević, S.; Sullivan, E.; Louie-Gao, M.; Schwaab, J.; Galinsky, I. A.; Perkins, C.; Sperr, W. R.; Sriskandarajah, P.; Chin, A.; Sendhil, S. R.; Duh, M. S.; Valent, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
905
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗